BRD4 and neuroblastoma: The use of dual PI3K/BRD4 inhibitors SF1126 or SF2523 blocks tumor growth, angiogenesis, stabilization of HIF1/2α, and polarization of M2 macrophages in solid tumors including neuroblastoma (131, 133–135).